Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Other Non-Current Assets (2018 - 2021)

Historic Other Non-Current Assets for Black Diamond Therapeutics (BDTX) over the last 4 years, with Q3 2021 value amounting to $1.2 million.

  • Black Diamond Therapeutics' Other Non-Current Assets changed 0.0% to $1.2 million in Q3 2021 from the same period last year, while for Sep 2021 it was $1.2 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $1.2 million for FY2020, which is 4689.54% down from last year.
  • According to the latest figures from Q3 2021, Black Diamond Therapeutics' Other Non-Current Assets is $1.2 million, which was down 0.0% from $1.2 million recorded in Q2 2021.
  • Black Diamond Therapeutics' 5-year Other Non-Current Assets high stood at $2.3 million for Q4 2019, and its period low was $8000.0 during Q4 2018.
  • For the 4-year period, Black Diamond Therapeutics' Other Non-Current Assets averaged around $786000.0, with its median value being $1.2 million (2020).
  • Per our database at Business Quant, Black Diamond Therapeutics' Other Non-Current Assets soared by 2868750.0% in 2019 and then tumbled by 4689.54% in 2020.
  • Over the past 4 years, Black Diamond Therapeutics' Other Non-Current Assets (Quarter) stood at $8000.0 in 2018, then soared by 28687.5% to $2.3 million in 2019, then tumbled by 46.9% to $1.2 million in 2020, then changed by 0.0% to $1.2 million in 2021.
  • Its last three reported values are $1.2 million in Q3 2021, $1.2 million for Q2 2021, and $1.2 million during Q1 2021.